期刊文献+

对影响早期子宫颈癌患者手术治疗的高危风险因素临床研究 被引量:2

Effects of high-risk factors on clinicaloutcomes of early-stagecervical cancer patients after surgical
原文传递
导出
摘要 目的探讨分析影响早期子宫颈癌患者手术治疗效果的高危风险因素,并观察上述因素对患者生存结局的影响。方法采用回顾性分析方法,选取早期(ⅠB~ⅡB期)宫颈癌患者98例,均经病理学证实且接受手术治疗。通过检测手术病理学风险因素,依据存在的风险因素数目将患者分组,组间比较手术疗效。结果存在1项风险因素者(单项组)33例(33.7%),存在多项(≥2项)者(多项组)23例(23.5%)。随访显示,多项组局部复发率和远处转移率高于单项组(P<0.05),而总生存期(OS)及无瘤生存期(DFS)低于单项组(P<0.05)。多项组中,接受同步放化疗者生存期均优于单纯放疗者(P<0.05)。结论在接受手术治疗的早期宫颈癌患者中,多项风险因素可降低手术效果和生存结局。同步放化疗有助于提高治疗效果。 Objective To investigate the effects of high-risk factors on clinical outcomes of early-stage cervical cancer patients after surgical. Methods Totally 98 cases of pathologically confirmed early-stage cervical cancer patients were selected,and all received surgical treatment. Thesurgical-pathological risk factors of patients were analyzed and grouping according to the number of high-risk factors. The surgical results of groups were compared. Results There were 1 risk factors(single group) in 33 cases(33. 7%),multiple high-risk factors(≥2)(multiple group) in23 cases(23. 5%).The local recurrence rate and distant metastasis rate of multiple group were higher than that of single group(P〈0. 05),but the overall survival(OS) and disease-free survival(DFS) were lower than those the single group(P〈0. 05). The survival time in patients treated with synchronism chemoradiation were better than those with radiotherapy alone in multiple group(P〈0. 05). Conclusion Multiple risk factors can reduce surgical outcomes and survival outcomes of early-stage cervical cancer patients after surgical,and synchronism chemoradiation is helpful to improve clinical outcomes.
作者 任莉 王焱 田晓予 REN Li WANG Yan TIAN Xiao -yu(College of Clinical Medicine of Henan University of Science and Technology, Lnoyang, Henan 471003 China)
出处 《医药论坛杂志》 2017年第1期18-19,共2页 Journal of Medical Forum
关键词 宫颈癌 早期 手术 放疗 化疗 生存结局 Cervical cancer Early-stage Synchronism chemoradiation Radiotherapy Chemotherapy Survival outcomes
  • 相关文献

参考文献4

二级参考文献40

  • 1王莉,刘风花,寇歆馨.HPB方案在宫颈鳞癌新辅助化疗中的应用[J].河南医学研究,2008,17(1):38-42. 被引量:4
  • 2万崇华,孟琼,汤学良,张灿珍,罗家洪,张晓磐.癌症患者生命质量测定量表FACT-G中文版评介[J].实用肿瘤杂志,2006,21(1):77-80. 被引量:406
  • 3杨艳,于廷和.ERCC1与顺铂耐药的研究进展[J].肿瘤,2007,27(12):1008-1009. 被引量:10
  • 4Ferrandina G,Margarity PA,Smaniotto D,et al.Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery[J].Gynecol Oncol,2010,119:404-410.
  • 5Colombo N,Peiretti M.Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer[J].Int J Gynecol Cancer,2010,20:S47-S48.
  • 6Arora P,Wadhwa R,Khurana N,et al.Secondary malignant fibrous histiocytoma of thigh with surface ulceration following radiotherapy for carcinoma cervix[J].Arch Gynecol Obstet,2011,283:79-82.
  • 7Azad SK,Choudhary V.Treatment results of radical radiotherapy of carcinoma uterine cervix using external beam radiotherapy and high dose rate intracavitary radiotherapy[J].J Cancer Res Ther,2010,6:482-486.
  • 8Sardi JE, bioxadera MA, sardi JJ. neoadjuvant chemotherapy in cervical caner :a new trend [ J]. Curr Opin Obstet Gynecol, 2005,17( 1 ) :43-47.
  • 9Whitney CW, Sause W, Bundy BN, et al. Randomized compari- son of fluorouracil plus cisplatin versus hydroxyurea as an ad- junct to radiation therapy in stages ⅡB - ⅣA carcinoma of the cervix with negative para- aortic lymph nodes: a Gynecologic Oneology Group and Southwest Oncology Group Study [ J ]. J Clin Oneol, 1999, 17(5): 1339-1348.
  • 10Choi CH, Kim TJ, Lee JW, et al. Phase II study of neoadjuvant chemotherapy with mitomycin - c, vincristine and cisplatin (MVC) in patient with stages Ib2 - IIb cervical carcinoma[ J]. Gynecol Oncol,2007,104( 1 ) :64-69.

共引文献12

同被引文献31

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部